Sharapova says failed drug test at Australian Open
Updated: 2016-03-08 04:52
Maria Sharapova speaks to the media announcing a failed drug test after the Australian Open during a press conference today at The LA Hotel Downtown, Los Angeles, CA, Mar 7, 2016. [Photo/Agencies]
LOS ANGELES - Former tennis world number one Maria Sharapova said on Monday that she failed a drug test at the Australian Open due to a substance she has been taking the last 10 years for health issues.
The 28-year-old Russian, a five-times grand slam champion, tested positive for meldonium, which is used to treat diabetes and low magnesium, and was only banned by the World Anti-Doping Agency as of Jan 1.
"I made a huge mistake. I let my fans down and I let the sport down. I have been playing since the age of four a sport that I love so deeply," Sharapova told a news conference in Los Angeles.
"I know that with this I face consequences and I don't want to end my career this way. I really hope that I will be given another chance to play this game."
The stunning news came a day after Sharapova's management team said she was going to make a "major announcement," which had many speculating that she was going to announce her retirement from professional tennis.
Sharapova, who has struggled with a series of injuries in recent years, has not competed since she lost to Serena Williams in the quarter-finals of the Australian Open in January.
"I was first given the substance back in 2006. I had several health issues going on at the time," said Sharapova.
"I was getting sick very often and I had a deficiency in magnesium and a family history of diabetes, and there were signs of diabetes. That is one of the medications, along with others, that I received."